Brokerages Set Select Medical Holdings Co. (NYSE:SEM) Price Target at $18.00

Shares of Select Medical Holdings Co. (NYSE:SEM) have been assigned an average recommendation of “Hold” from the seven analysts that are currently covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $18.00.

Several analysts have recently weighed in on SEM shares. TheStreet raised shares of Select Medical from a “c+” rating to a “b-” rating in a research note on Thursday, June 27th. Deutsche Bank started coverage on shares of Select Medical in a research note on Monday, September 16th. They issued a “buy” rating and a $22.00 price target for the company.

SEM stock traded down $0.21 during mid-day trading on Thursday, reaching $16.70. The company’s stock had a trading volume of 307,930 shares, compared to its average volume of 595,222. The stock has a market cap of $2.29 billion, a PE ratio of 16.21, a P/E/G ratio of 1.16 and a beta of 1.33. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 4.18. Select Medical has a fifty-two week low of $12.96 and a fifty-two week high of $20.24. The company’s 50 day moving average is $16.34 and its two-hundred day moving average is $15.25.



Select Medical (NYSE:SEM) last released its quarterly earnings data on Thursday, August 1st. The health services provider reported $0.33 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.33. The company had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.34 billion. Select Medical had a net margin of 2.73% and a return on equity of 14.79%. Select Medical’s quarterly revenue was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.31 EPS. On average, analysts forecast that Select Medical will post 1.05 earnings per share for the current fiscal year.

In other news, SVP Scott A. Romberger sold 9,344 shares of the stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $17.26, for a total value of $161,277.44. Following the completion of the sale, the senior vice president now owns 146,620 shares of the company’s stock, valued at approximately $2,530,661.20. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Robert G. Breighner, Jr. sold 3,589 shares of the stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $15.22, for a total transaction of $54,624.58. Following the completion of the sale, the vice president now directly owns 33,035 shares of the company’s stock, valued at approximately $502,792.70. The disclosure for this sale can be found here. Corporate insiders own 19.50% of the company’s stock.

Several institutional investors have recently bought and sold shares of the company. Macquarie Group Ltd. purchased a new position in shares of Select Medical during the 2nd quarter worth approximately $1,320,000. BlackRock Inc. boosted its position in shares of Select Medical by 1.2% during the 2nd quarter. BlackRock Inc. now owns 16,931,926 shares of the health services provider’s stock worth $268,711,000 after purchasing an additional 207,146 shares during the period. Royal Bank of Canada boosted its position in shares of Select Medical by 105.6% during the 2nd quarter. Royal Bank of Canada now owns 3,862 shares of the health services provider’s stock worth $62,000 after purchasing an additional 1,984 shares during the period. Ladenburg Thalmann Financial Services Inc. boosted its position in shares of Select Medical by 79.7% during the 2nd quarter. Ladenburg Thalmann Financial Services Inc. now owns 5,412 shares of the health services provider’s stock worth $86,000 after purchasing an additional 2,400 shares during the period. Finally, Nuveen Asset Management LLC boosted its position in shares of Select Medical by 4,746.3% during the 2nd quarter. Nuveen Asset Management LLC now owns 1,650,648 shares of the health services provider’s stock worth $26,196,000 after purchasing an additional 1,616,588 shares during the period. 75.47% of the stock is owned by institutional investors and hedge funds.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates through four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Featured Story: Street Name

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.